Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success
Alexandre Xu-Vuillard, Bruno Duso, Banu Arun, Judith Balmañà et autres
0 citationsESMO Open
Vall d'Hebron Institute of Oncology
Barcelona · ES · healthcare
5868Publications signalées
548411Citations signalées
12Thèmes principaux
Principaux domaines
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and StudiesPARP inhibition in cancer therapyCancer Treatment and PharmacologyLung Cancer Research StudiesBreast Cancer Treatment StudiesCAR-T cell therapy researchPancreatic and Hepatic Oncology Research
Évolution annuelle
Publications récentes
Validating the biological origin of in vivo fractional intracellular volume from VERDICT-MRI in the prostate
Marta Masramon, Manju Mathew, Saurabh Singh, Thomy Mertzanidou et autres
0 citationsEuropean Radiology Experimental
The RNA cargo of plasma-derived extracellular vesicles in mCRPC patients captures cancer cells and tumor microenvironment signals
Federico Vannuccini, Yari Ciani, Vera Mugoni, Orsetta Quaini et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors
Ecaterina E. Dumbrava, Do-Youn Oh, Min‐Hee Ryu, Emiliano Calvo et autres
0 citationsJournal for ImmunoTherapy of Cancer
Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers
Stephanie M. Wong, Eva Blondeaux, Virginia Delucchi, Florence Coussy et autres
0 citationsJAMA Network Open
RNA splicing evidence enables robust classification of BRCA1 exon 18 variants: Results from the ENIGMA consortium
Joanna Domènech-Vivó, Hélène Tubeuf, Romy L.S. Mesman, Aurélie Drouet et autres
0 citationsThe American Journal of Human Genetics
Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open‐label, phase 2 trial
Silvia Stacchiotti, Jean‐Yves Blay, Piotr Rutkowski, Hans Gelderblom et autres
0 citationsCancer
Early and late CTCAE and patient-reported outcomes following lung cancer radiotherapy: A sex-stratified descriptive analysis from the REQUITE cohort
E. Aguado-Barrera Miguel, Calvo-Crespo Patricia, Taboada-Valladares Begoña, Gomez-Caamano Antonio et autres
0 citationsClinical and Translational Radiation Oncology
Technical note: reconstructing dose distributions from manually planned electron boosts in breast radiotherapy
Tanwiwat Jaikuna, Isobel Dawes, Hannah Chamberlin, D. Azria et autres
0 citationsPhysica Medica
From Cells to Survival: Hierarchical Analysis of Cell Inter-relations in Multiplex Microscopy for Lung Cancer Prognosis
Olle Edgren Schüllerqvist, Jens Baumann, Joakim Lindblad, Love Nordling et autres
0 citationsLecture notes in computer science
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era
Juan Carlos Hernández‐Boluda, Eduardo Arellano‐Rodrigo, Manuel Pérez‐Encinas, José‐María Raya et autres
0 citationsBritish Journal of Haematology
Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group
Alberto Carmona‐Bayonas, A. Mariño Méndez, Maria Angeles Vicente-Conesa, Paula Jiménez‐Fonseca et autres
1 citationPancreatology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.